IL156262A0 - Anti-cd28 antibodies having no mitogenic activity and pharmaceutical compositions containing the same - Google Patents
Anti-cd28 antibodies having no mitogenic activity and pharmaceutical compositions containing the sameInfo
- Publication number
- IL156262A0 IL156262A0 IL15626201A IL15626201A IL156262A0 IL 156262 A0 IL156262 A0 IL 156262A0 IL 15626201 A IL15626201 A IL 15626201A IL 15626201 A IL15626201 A IL 15626201A IL 156262 A0 IL156262 A0 IL 156262A0
- Authority
- IL
- Israel
- Prior art keywords
- antibodies
- same
- pharmaceutical compositions
- compositions containing
- mitogenic activity
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2818—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD28 or CD152
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/54—F(ab')2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/55—Fab or Fab'
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Surgery (AREA)
- Transplantation (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25515500P | 2000-12-14 | 2000-12-14 | |
PCT/US2001/047955 WO2002047721A1 (en) | 2000-12-14 | 2001-12-14 | Silensed anti-cd28 antibodies and use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
IL156262A0 true IL156262A0 (en) | 2004-01-04 |
Family
ID=22967074
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL15626201A IL156262A0 (en) | 2000-12-14 | 2001-12-14 | Anti-cd28 antibodies having no mitogenic activity and pharmaceutical compositions containing the same |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP1341553A4 (ru) |
JP (1) | JP2004515243A (ru) |
KR (1) | KR20040020866A (ru) |
CN (1) | CN1272345C (ru) |
AR (1) | AR031924A1 (ru) |
AU (2) | AU2608602A (ru) |
BR (1) | BR0116686A (ru) |
CA (1) | CA2432736A1 (ru) |
CZ (1) | CZ20031909A3 (ru) |
HU (1) | HUP0400697A3 (ru) |
IL (1) | IL156262A0 (ru) |
MX (1) | MXPA03005327A (ru) |
NO (1) | NO20032542L (ru) |
NZ (1) | NZ526569A (ru) |
PL (1) | PL363239A1 (ru) |
RU (1) | RU2261723C2 (ru) |
WO (1) | WO2002047721A1 (ru) |
ZA (1) | ZA200305384B (ru) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002066059A2 (en) | 2001-02-16 | 2002-08-29 | Genetics Institute, Llc | Agents that specifically block cd28-mediated signaling and uses therefor |
US20080095774A1 (en) * | 2001-02-16 | 2008-04-24 | Wyeth | Agents and Methods for Specifically Blocking CD28-Mediated Signaling |
WO2006138181A2 (en) | 2005-06-14 | 2006-12-28 | Amgen Inc. | Self-buffering protein formulations |
FR2951176A1 (fr) * | 2009-10-09 | 2011-04-15 | Tcl Pharma | Ligands monovalents du recepteur cd28 humain |
PL2536764T3 (pl) * | 2010-02-18 | 2018-12-31 | Ose Immunotherapeutics | Humanizowane przeciwciała anty-CD28 |
CN114917185B (zh) | 2016-10-21 | 2023-11-14 | 美国安进公司 | 药物配制品及其制备方法 |
CA3103629A1 (en) | 2018-06-15 | 2019-12-19 | Flagship Pioneering Innovations V, Inc. | Increasing immune activity through modulation of postcellular signaling factors |
CN113692286A (zh) * | 2019-03-14 | 2021-11-23 | 比昂生物制剂公司 | 一种用于免疫抑制的方法 |
WO2020227159A2 (en) | 2019-05-03 | 2020-11-12 | Flagship Pioneering Innovations V, Inc. | Methods of modulating immune activity |
EP4076434A1 (en) | 2019-12-17 | 2022-10-26 | Flagship Pioneering Innovations V, Inc. | Combination anti-cancer therapies with inducers of iron-dependent cellular disassembly |
JP2023532339A (ja) | 2020-06-29 | 2023-07-27 | フラグシップ パイオニアリング イノベーションズ ブイ,インコーポレーテッド | サノトランスミッションを促進するためにエンジニアリングされたウイルス及び癌の処置におけるそれらの使用 |
KR20230166150A (ko) | 2020-08-19 | 2023-12-06 | 젠코어 인코포레이티드 | 항-cd28 조성물 |
US20220325287A1 (en) | 2021-03-31 | 2022-10-13 | Flagship Pioneering Innovations V, Inc. | Thanotransmission polypeptides and their use in treating cancer |
CA3224374A1 (en) | 2021-06-29 | 2023-01-05 | Flagship Pioneering Innovations V, Inc. | Immune cells engineered to promote thanotransmission and uses thereof |
WO2024040194A1 (en) | 2022-08-17 | 2024-02-22 | Capstan Therapeutics, Inc. | Conditioning for in vivo immune cell engineering |
US20240174732A1 (en) | 2022-10-05 | 2024-05-30 | Flagship Pioneering Innovations V, Inc. | Nucleic acid molecules encoding trif and additional polypeptides and their use in treating cancer |
WO2024148336A1 (en) * | 2023-01-06 | 2024-07-11 | Igm Biosciences, Inc. | T cell costimulatory multimeric binding molecules and uses thereof |
US20240269251A1 (en) | 2023-01-09 | 2024-08-15 | Flagship Pioneering Innovations V, Inc. | Genetic switches and their use in treating cancer |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5580756A (en) * | 1990-03-26 | 1996-12-03 | Bristol-Myers Squibb Co. | B7Ig fusion protein |
-
2001
- 2001-12-14 AR ARP010105828A patent/AR031924A1/es unknown
- 2001-12-14 AU AU2608602A patent/AU2608602A/xx active Pending
- 2001-12-14 BR BR0116686-7A patent/BR0116686A/pt not_active IP Right Cessation
- 2001-12-14 AU AU2002226086A patent/AU2002226086C1/en not_active Ceased
- 2001-12-14 RU RU2003121231/15A patent/RU2261723C2/ru not_active IP Right Cessation
- 2001-12-14 KR KR10-2003-7007798A patent/KR20040020866A/ko not_active Application Discontinuation
- 2001-12-14 PL PL01363239A patent/PL363239A1/xx not_active Application Discontinuation
- 2001-12-14 WO PCT/US2001/047955 patent/WO2002047721A1/en not_active Application Discontinuation
- 2001-12-14 HU HU0400697A patent/HUP0400697A3/hu unknown
- 2001-12-14 EP EP01995504A patent/EP1341553A4/en not_active Withdrawn
- 2001-12-14 JP JP2002549291A patent/JP2004515243A/ja not_active Withdrawn
- 2001-12-14 CA CA002432736A patent/CA2432736A1/en not_active Abandoned
- 2001-12-14 CZ CZ20031909A patent/CZ20031909A3/cs unknown
- 2001-12-14 MX MXPA03005327A patent/MXPA03005327A/es unknown
- 2001-12-14 NZ NZ526569A patent/NZ526569A/en unknown
- 2001-12-14 CN CNB018226361A patent/CN1272345C/zh not_active Expired - Fee Related
- 2001-12-14 IL IL15626201A patent/IL156262A0/xx unknown
-
2003
- 2003-06-05 NO NO20032542A patent/NO20032542L/no not_active Application Discontinuation
- 2003-07-11 ZA ZA200305384A patent/ZA200305384B/en unknown
Also Published As
Publication number | Publication date |
---|---|
MXPA03005327A (es) | 2004-12-03 |
CN1489473A (zh) | 2004-04-14 |
ZA200305384B (en) | 2004-10-11 |
HUP0400697A3 (en) | 2007-05-02 |
AU2608602A (en) | 2002-06-24 |
RU2003121231A (ru) | 2005-02-10 |
WO2002047721A1 (en) | 2002-06-20 |
JP2004515243A (ja) | 2004-05-27 |
PL363239A1 (en) | 2004-11-15 |
CN1272345C (zh) | 2006-08-30 |
EP1341553A4 (en) | 2004-07-28 |
AU2002226086B2 (en) | 2005-08-25 |
CZ20031909A3 (cs) | 2003-11-12 |
NO20032542L (no) | 2003-08-07 |
EP1341553A1 (en) | 2003-09-10 |
NO20032542D0 (no) | 2003-06-05 |
BR0116686A (pt) | 2003-12-30 |
CA2432736A1 (en) | 2002-06-20 |
HUP0400697A2 (hu) | 2004-06-28 |
AU2002226086C1 (en) | 2006-03-09 |
AR031924A1 (es) | 2003-10-08 |
KR20040020866A (ko) | 2004-03-09 |
RU2261723C2 (ru) | 2005-10-10 |
NZ526569A (en) | 2005-07-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL164021A (en) | Anti-αvβ6 antibodies and their pharmaceutical preparations | |
HUP0200714A3 (en) | Pharmaceutical compounds, pharmaceutical compositions containing them and their use | |
ZA200110022B (en) | Thiazoloderivatives and pharmaceutical compositions containing them. | |
HUP0302969A3 (en) | Npyy5 antagonists, pharmaceutical compositions containing them and their use | |
IL138280A0 (en) | 20-KETO-11β-ARYLSTERIODS, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND METHODS FOR THE PREPARATION THEREOF | |
HUP0204514A3 (en) | Pyridinylimidazoles, pharmaceutical compositions containing them and their use | |
HUP0204413A3 (en) | Quinazoline compounds, their preparation, their use and pharmaceutical compositions containing them | |
HUP0204081A3 (en) | 4-pyrimidinyl-n-acyl-l-phenylalanines, pharmaceutical compositions containing them and their use | |
HUP0203939A3 (en) | Pharmaceutical compounds and compositions containing them and their use | |
GC0000307A (en) | Pyrimidone compounds and pharmaceutical composition containing them | |
HUP0301573A3 (en) | Substituted arylpyrazines, pharmaceutical compositions containing them and their use | |
HUP0103884A3 (en) | Arylsulfonanilide urea-derivatives, pharmaceutical compositions containing them and their use | |
HUP0402566A3 (en) | C-5 modified indazolylamino pyrrolotriazines, their use and pharmaceutical compositions containing them | |
HUP0301777A3 (en) | Aniline-derived ligands for the thyroid receptor, pharmaceutical compositions comprising thereof and their use | |
HUP0200312A3 (en) | Substituted 2-phenylbenzimidazoles, pharmaceutical compositions containing them, the production thereof and their use | |
IL150224A0 (en) | Lipopeptides and pharmaceutical compositions containing the same | |
HUP0102372A3 (en) | Dihydropyrimidines, preparation thereof and pharmaceutical compositions containing the same | |
IL150223A0 (en) | Lipopeptides and pharmaceutical compositions containing the same | |
ZA200202996B (en) | Hair treatment compositions comprising particulate substances. | |
HUP0204071A3 (en) | Nitrogenous cyclic compounds and pharmaceutical compositions containing the same and their use | |
IL156262A0 (en) | Anti-cd28 antibodies having no mitogenic activity and pharmaceutical compositions containing the same | |
HUP0202781A3 (en) | Betha-carboline particulate form, pharmaceutical compositions containing it, their preparations and their use | |
HUP0203194A3 (en) | Phenylpiperazines, pharmaceutical compositions containing them and their use | |
HUP0203735A3 (en) | 4-pyridinyl-n-acyl-l-phenylalanines, pharmaceutical compositions containing them and their use | |
IL150383A0 (en) | Glyburide and pharmaceutical compositions containing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
HC | Change of name of proprietor(s) |